X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (393) 393
Publication (24) 24
Book Chapter (22) 22
Book / eBook (6) 6
Patent (5) 5
Book Review (4) 4
Conference Proceeding (4) 4
Web Resource (3) 3
Reference (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (206) 206
oncology (155) 155
index medicus (114) 114
female (101) 101
male (94) 94
aged (86) 86
middle aged (79) 79
cancer (69) 69
chemotherapy (58) 58
lung cancer (53) 53
prognosis (53) 53
adult (52) 52
lung neoplasms - pathology (44) 44
survival (33) 33
treatment outcome (33) 33
aged, 80 and over (32) 32
internal medicine (32) 32
antineoplastic combined chemotherapy protocols - therapeutic use (31) 31
lung neoplasms - drug therapy (30) 30
carcinoma, non-small-cell lung - pathology (29) 29
neoplasm staging (28) 28
animals (25) 25
medicine & public health (25) 25
research (25) 25
expression (24) 24
tumors (24) 24
carcinoma, non-small-cell lung - drug therapy (23) 23
metastasis (23) 23
therapy (23) 23
breast-cancer (22) 22
carcinoma (22) 22
antineoplastic agents - therapeutic use (21) 21
hematology, oncology and palliative medicine (21) 21
lung cancer, non-small cell (21) 21
analysis (20) 20
care and treatment (20) 20
diagnosis (20) 20
lung neoplasms - mortality (20) 20
mutation (20) 20
respiratory system (20) 20
survival analysis (20) 20
pancreatic neoplasms (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (18) 18
nsclc (18) 18
pancreatic neoplasms - drug therapy (18) 18
review (18) 18
surgery (17) 17
survival rate (17) 17
adenocarcinoma (16) 16
immunohistochemistry (16) 16
medicine, research & experimental (16) 16
cell lung-cancer (15) 15
erlotinib (15) 15
lung neoplasms - metabolism (15) 15
pathology (15) 15
retrospective studies (15) 15
biomarkers, tumor - metabolism (14) 14
gemcitabine (14) 14
hematology (14) 14
lung neoplasms - genetics (14) 14
neoplasm metastasis (14) 14
non-small cell lung cancer (14) 14
pancreatic neoplasms - pathology (14) 14
cells (13) 13
deoxycytidine - analogs & derivatives (13) 13
health aspects (13) 13
immunology (13) 13
lung neoplasms - diagnosis (13) 13
nuclear medicine (13) 13
pharmacology & pharmacy (13) 13
protein expression (13) 13
biomarkers, tumor - genetics (12) 12
growth-factor receptor (12) 12
paclitaxel (12) 12
pancreatic cancer (12) 12
pulmonary/respiratory (12) 12
risk factors (12) 12
adenocarcinoma - pathology (11) 11
cancer research (11) 11
carcinoma, non-small-cell lung - genetics (11) 11
carcinoma, non-small-cell lung - mortality (11) 11
cell line, tumor (11) 11
disease progression (11) 11
genetic aspects (11) 11
management (11) 11
patient outcomes (11) 11
taxoids - administration & dosage (11) 11
angiogenesis (10) 10
antineoplastic agents - administration & dosage (10) 10
antineoplastic agents - adverse effects (10) 10
article (10) 10
biomarkers (10) 10
biomarkers, tumor - blood (10) 10
cohort studies (10) 10
colorectal cancer (10) 10
combination (10) 10
deoxycytidine - administration & dosage (10) 10
disease-free survival (10) 10
drug therapy (10) 10
egfr (10) 10
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2014, Volume 384, Issue 9944, pp. 665 - 673
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 8, pp. 897 - 907
Journal Article
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 06/2012, Volume 12, Issue 1, pp. 271 - 271
Background: The aim was to compare two standard chemotherapy regimens combined with bevacizumab as first-line treatment in patients with metastatic colorectal... 
Irinotecan | Chemotherapy | Capecitabine | Angiogenic markers | Colorectal cancer | Bevacizumab | COLON-CANCER | OSTEOPONTIN | ONCOLOGY | NITRIC-OXIDE | ORAL FLUOROPYRIMIDINES | BICC-C | EXPRESSION | CARCINOMA | ENDOTHELIAL GROWTH-FACTOR | Osteopontin - blood | Leucovorin - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Antineoplastic Agents - administration & dosage | Neoplasm Metastasis | Antibodies, Monoclonal, Humanized - administration & dosage | Fluorouracil - administration & dosage | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Treatment Outcome | Biomarkers - blood | Angiogenic Proteins - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Neoplasm Staging | Deoxycytidine - analogs & derivatives | Care and treatment | Patient outcomes | Research | Comparative analysis | Cancer | Clinical trials | Leucovorin | Metastasis | Antineoplastic agents | Antimitotic agents | Cancer patients | Nitric oxide | Product development | Vascular endothelial growth factor | Growth factors
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 10/2014, Volume 8, pp. 1753 - 1763
Pulmonary hypertension is a disease with severe consequences for the human body. There are several diseases and situations that induce pulmonary hypertension... 
Imatinib | Jet nebulizers | Erlotinib | Gefitinib | Ultrasound nebulizers | CHEMISTRY, MEDICINAL | erlotinib | RATS | imatinib | gefitinib | CELL LUNG-CANCER | THERAPY | AEROSOL CHEMOTHERAPY | ARTERIAL-HYPERTENSION | GROWTH | jet nebulizers | PHARMACOLOGY & PHARMACY | ultrasound nebulizers | VEGF RECEPTOR INHIBITOR | PRODUCTION SYSTEMS | Erlotinib Hydrochloride | Piperazines - administration & dosage | Pyrimidines - administration & dosage | Humans | Administration, Inhalation | Piperazines - therapeutic use | Imatinib Mesylate | Protein Kinase Inhibitors - administration & dosage | Benzamides - administration & dosage | Benzamides - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Quinazolines - therapeutic use | Quinazolines - administration & dosage | Hypertension, Pulmonary - drug therapy | Enzyme inhibitors | Physiological aspects | Research | Drug therapy | Health aspects | Protein kinases | Pulmonary hypertension | Heart | Drugs | Intravenous administration | Syngeneic grafts | Medical services | Lung transplantation | Smooth muscle | Food science | Kinases | Powder | Mouthguards | Ultrasonic imaging | Experimentation | Droplets | Inhalers | Thromboembolism | Protein-tyrosine kinase | Ultrasound | Heart failure | Hypertension | Tyrosine | Ventilators | Pulmonary arteries | Lung diseases | Medical treatment | Heart transplantation | Angina pectoris | Catheters | Investigations | Hospitals | Inhibitors | Hypoxia | In vivo methods and tests | Intubation | Veins & arteries
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2015, Volume 33, Issue 15_suppl, pp. e15198 - e15198
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13, pp. 3634 - 3644
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2019, Volume 143, Issue 2, pp. AB176 - AB176
Journal Article
Current Pharmaceutical Design, ISSN 1381-6128, 2010, Volume 16, Issue 20, pp. 2184 - 2193
Even though treatment of several types of solid tumors has improved in the past few years with the introduction of molecular targeted agents in the therapeutic... 
Molecular targeted therapy | Pharmacogenetics | Individualized treatment | Cancer | FUNCTIONAL POLYMORPHISM | FC-GAMMA-RIIIA | GASTROINTESTINAL-STROMAL-TUMORS | DINUCLEOTIDE REPEAT POLYMORPHISM | CELL LUNG-CANCER | BREAST-CANCER | GROWTH-FACTOR RECEPTOR | EGF GENE | CETUXIMAB PLUS IRINOTECAN | individualized treatment | PHARMACOLOGY & PHARMACY | molecular targeted therapy | MUTATIONS | pharmacogenetics | Neoplasms - metabolism | Receptor, ErbB-2 - genetics | Humans | ErbB Receptors - genetics | Receptor, ErbB-2 - metabolism | Receptors, Vascular Endothelial Growth Factor - drug effects | Neoplasm Proteins - metabolism | Neoplasm Proteins - drug effects | Receptors, Growth Factor - genetics | Molecular Targeted Therapy - trends | Receptors, Vascular Endothelial Growth Factor - metabolism | Neoplasms - genetics | Receptors, Vascular Endothelial Growth Factor - genetics | Neoplasm Proteins - genetics | Receptor, ErbB-2 - drug effects | Pharmacogenetics - methods | ErbB Receptors - metabolism | ErbB Receptors - drug effects | Polymorphism, Genetic - drug effects | Neoplasms - drug therapy | Mutation - drug effects | Drug Therapy - methods | Receptors, Growth Factor - drug effects | Precision Medicine - methods | Receptors, Growth Factor - metabolism | Epidermal growth factor receptors | Clinical trials | Data processing | Oncology | ErbB-2 protein | Gene polymorphism | Vascular endothelial growth factor receptors | Reviews | Monoclonal antibodies | Genetic factors | Mutation | Solid tumors | Protein-tyrosine kinase
Journal Article